标题
Drug–drug interactions during antiviral therapy for chronic hepatitis C
作者
关键词
-
出版物
Nature Reviews Gastroenterology & Hepatology
Volume 10, Issue 10, Pages 596-606
出版商
Springer Nature
发表日期
2013-07-02
DOI
10.1038/nrgastro.2013.106
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacokinetic Interaction between Telaprevir and Methadone
- (2013) Rolf van Heeswijk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype1 HCV: SILEN-C1 trial
- (2013) Mark S. Sulkowski et al. HEPATOLOGY
- Lack of a clinically significant drug-drug interaction in healthy volunteers between the HCV protease inhibitor boceprevir and the proton pump inhibitor omeprazole
- (2013) C. T. M. M. de Kanter et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1
- (2013) Eric Lawitz et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial
- (2013) Kris V Kowdley et al. LANCET
- Effect of telaprevir on the pharmacokinetics of sirolimus in liver transplant recipients
- (2013) Jacqueline G. O'Leary et al. LIVER TRANSPLANTATION
- Drug-grapefruit juice interactions
- (2013) M. Pirmohamed BMJ-British Medical Journal
- Effect of Milk Thistle on the Pharmacokinetics of Darunavir-Ritonavir in HIV-Infected Patients
- (2012) José Moltó et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interaction of the antiviral drug telaprevir with renal and hepatic drug transporters
- (2012) Annett Kunze et al. BIOCHEMICAL PHARMACOLOGY
- Lack of a Clinically Significant Drug–Drug Interaction in Healthy Volunteers Between the Hepatitis C Virus Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir
- (2012) Clara T. M. M. de Kanter et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir
- (2012) Ellen G. J. Hulskotte et al. CLINICAL INFECTIOUS DISEASES
- Single-Dose Pharmacokinetics of Boceprevir in Subjects with Impaired Hepatic or Renal Function
- (2012) Michelle Treitel et al. CLINICAL PHARMACOKINETICS
- Management of the Transplant Recipient with Chronic Hepatitis C
- (2012) James R. Burton et al. Clinics in Liver Disease
- Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?
- (2012) Alexander J. Thompson et al. HEPATOLOGY
- Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers
- (2012) Ellen Hulskotte et al. HEPATOLOGY
- Review and management of drug interactions with boceprevir and telaprevir
- (2012) Jennifer J. Kiser et al. HEPATOLOGY
- Pharmacokinetic Interaction Between Boceprevir and Etravirine in HIV/HCV Seronegative Volunteers
- (2012) Kyle P. Hammond et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- 1130 THE EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS AND ANTIVIRAL ACTIVITY OF PSI-7977 IN HEPATITIS C INFECTED SUBJECTS TREATED FOR SEVEN DAYS
- (2012) E. Lawitz et al. JOURNAL OF HEPATOLOGY
- 11 SUSTAINED VIROLOGIC RESPONSE (SVR) IN PRIOR PEGINTERFERON/RIBAVIRIN (PR) TREATMENT FAILURES AFTER RETREATMENT WITH BOCEPREVIR (BOC)-+-PR: THE PROVIDE STUDY INTERIM RESULTS
- (2012) J.P. Bronowicki et al. JOURNAL OF HEPATOLOGY
- 538 IMPROVED PREDICTIVE VALUE FOR SUSTAINED IMMUNE CONTROL IN PEGINTERFERON ALFA-2A (40KD) (PEGASYS)-TREATED HBEAG-POSITIVE PATIENTS USING COMBINED HBSAG AND HBV DNA LEVELS AT WEEK 24
- (2012) T. Piratvisuth et al. JOURNAL OF HEPATOLOGY
- Mechanistic biomarkers in acute liver injury: Are we there yet?
- (2012) Danielle Adebayo et al. JOURNAL OF HEPATOLOGY
- 1101 THE EFFECT OF RENAL IMPAIRMENT AND END STAGE RENAL DISEASE ON THE SINGLE-DOSE PHARMACOKINETICS OF PSI-7977
- (2012) M.T. Cornpropst et al. JOURNAL OF HEPATOLOGY
- Clinical management of drug–drug interactions in HCV therapy: Challenges and solutions
- (2012) David Burger et al. JOURNAL OF HEPATOLOGY
- Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: A 12-week pilot study providing safety and efficacy data
- (2012) Christoph R. Werner et al. LIVER TRANSPLANTATION
- Opioid Metabolism
- (2012) Howard S. Smith MAYO CLINIC PROCEEDINGS
- Ritonavir-boosted protease inhibitors in HIV therapy
- (2011) Mark W. Hull et al. ANNALS OF MEDICINE
- Cushing's Syndrome Due to Antiretroviral-Budesonide Interaction
- (2011) Jonathan K Frankel et al. ANNALS OF PHARMACOTHERAPY
- Provisional Guidance on the Use of Hepatitis C Virus Protease Inhibitors for Treatment of Hepatitis C in HIV-Infected Persons
- (2011) D. L. Thomas et al. CLINICAL INFECTIOUS DISEASES
- Second-wave Protease Inhibitors: Choosing an Heir
- (2011) Sandra Ciesek et al. Clinics in Liver Disease
- The NS5A Replication Complex Inhibitors: Difference Makers?
- (2011) Robert G. Gish et al. Clinics in Liver Disease
- Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus
- (2011) Varun Garg et al. HEPATOLOGY
- Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1
- (2011) Richard E. Nettles et al. HEPATOLOGY
- Influence ofPanax ginsengon Cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) Activity in Healthy Participants
- (2011) Christine Y. Malati et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Pharmacokinetic Interaction Between an Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone and the HCV Protease Inhibitor Telaprevir
- (2011) Varun Garg et al. JOURNAL OF CLINICAL PHARMACOLOGY
- 1204 PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE HCV NS5A INHIBITOR ABT-267 FOLLOWING SINGLE AND MULTIPLE DOSES IN HEALTHY ADULT VOLUNTEERS
- (2011) E.O. Dumas et al. JOURNAL OF HEPATOLOGY
- 472 PHARMACOKINETICS OF TMC435 IN SUBJECTS WITH MODERATE HEPATIC IMPAIRMENT
- (2011) V. Sekar et al. JOURNAL OF HEPATOLOGY
- 1236 MECHANISMS OF ISOLATED UNCONJUGATED HYPERBILIRUBINEMIA INDUCED BY THE HCV NS3/4A PROTEASE INHIBITOR BI201335
- (2011) R. Sane et al. JOURNAL OF HEPATOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs
- (2011) Alice Tseng et al. Current Infectious Disease Reports
- Herb-Drug Interaction betweenEchinacea purpureaand Darunavir-Ritonavir in HIV-Infected Patients
- (2010) José Moltó et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Echinacea purpureaSignificantly Induces Cytochrome P450 3A Activity but Does Not Alter Lopinavir-Ritonavir Exposure in Healthy Subjects
- (2010) Scott R Penzak et al. PHARMACOTHERAPY
- Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
- (2010) Megan H. Powdrill et al. Viruses-Basel
- Cellular and molecular biology of HCV infection and hepatitis
- (2009) Hengli Tang et al. CLINICAL SCIENCE
- 955 PRECLINICAL POTENCY, PHARMACOKINETIC AND ADME CHARACTERIZATION OF ABT-333, A NOVEL NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR
- (2009) C. Maring et al. JOURNAL OF HEPATOLOGY
- Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects
- (2008) Sarah M. Robertson et al. CURRENT MEDICAL RESEARCH AND OPINION
- Viral hepatitis and HIV coinfection
- (2007) Mark S. Sulkowski JOURNAL OF HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search